Copyright news18
New Delhi, Nov 4 (PTI) Alembic Pharmaceuticals on Tuesday said its consolidated net profit increased 21 per cent year-on-year to Rs 185 crore in the second quarter ended September 30, 2025. The drug firm reported a net profit of Rs 153 crore during the July-September quarter of the last fiscal. Revenue from operations rose to Rs 1,910 crore for the September quarter, as compared with Rs 1,648 crore in the year-ago period, Alembic Pharmaceuticals said in a regulatory filing. The drug firm said its US formulations business reported sales of Rs 639 crore in the second quarter, a year-on-year increase of 5 per cent as against Rs 609 crore. Similarly, US formulations business sales grew 21 per cent on-year to Rs 566 crore in the September quarter, it added. Shares of Alembic Pharma ended 3.87 per cent up at Rs 960.10 apiece on the BSE. PTI MSS MSS SHW
